Investigation of insulin resistance-induced endoplasmic reticulum stress in the pancreatic β-cell and development of diabetes mellitus
Investigation of insulin resistance-induced endoplasmic reticulum stress in the pancreatic β-cell and development of diabetes mellitus
批准号:
18390103
负责人:
TANIZAWA Yukio
金额:
$10.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
越来越多的证据表明β-细胞质量的减少在2型糖尿病的发生发展中起着重要的作用。内质网应激最近被认为是β细胞损失的一种候选机制。我们以Wfs1敲除小鼠为模型研究了这一机制。WFS1基因编码一种内质网(ER)膜嵌入蛋白,其纯合突变导致人类选择性β细胞丢失。WFS1蛋白参与内质网应激反应,但缺乏WFS1的β细胞死亡机制尚不完全清楚。有趣的是,Wfs1^<-/->小鼠的表型主要取决于它们的遗传背景。具有C57BL/6J基因背景的Wfs1^<-/->小鼠不会发生显性糖尿病。然而,我们发现,当这些小鼠由于agouti致命黄色突变(Wfs1^<-/-> ^y/ A)而变得轻度肥胖和胰岛素抵抗时,它们早在16周就出现选择性β细胞丢失和严重的胰岛素缺乏性糖尿病。在A^y/ A小鼠胰岛中,ER伴侣Bip/GRP78表达和EIF2□磷酸化升高,提示肥胖诱导β-细胞内质网应激。与Wfs1^<-/->或A^y/ A小鼠相比,Wfs1^<-/->或A^y/ A小鼠中Bip/GRP78蛋白的表达进一步增加。电镜显示β-细胞内质网明显扩张,胰岛素颗粒减少,提示胰岛素抵抗引起内质网应激,缺乏Wfs1的胰腺β-细胞更容易发生内质网应激诱导的凋亡。有趣的是,吡格列酮治疗几乎完全预防糖尿病,并保护β细胞免于凋亡。在胰岛中,尽管ER伴侣表达无差异,但CHOP表达降低。虽然Wolfram综合征是一种独特的疾病,但在2型糖尿病患者中可能存在共同的过程,包括缓慢但进行性的β细胞损失,其中胰岛素需求由于胰岛素抵抗而持续上升。该模型的研究有望为β细胞损失的机制和预防提供见解。少
英文摘要
There are accumulating evidences that decrease in β-cell mass play roles in the development and progression of type 2 diabetes mellitus. Endoplasmic reticulum stress has recently emerged as a candidate mechanism of β-cell loss. We investigated this mechanism using Wfs1 knock-out mouse as a model. The WFS1 gene encodes an endoplasmic reticulum (ER) membrane-embedded protein, homozygous mutations of which cause selective β-cell loss in humans. The WFS1 protein is involved in ER stress responses, but the mechanism of β-cell death in WFS1-deficient β-cells is still not fully understood. Interestingly, the phenotype of Wfs1^<-/-> mice depends mainly on their genetic backgrounds. Wfs1^<-/-> mice with the C57BL/6J background do not develop overt diabetes. However, we found that when these mice become mildly obese and insulin resistant due to the agouti lethal yellow mutation (Wfs1^<-/-> A^y/a), they develop selective β-cell loss and severe insulin-deficient diabetes as early as 16 weeks of ag … More e. This β-cell loss appeared to be due to apoptosis. In A^y/a murine islets, ER chaperone Bip/GRP78 expression and EIF2□ phosphorylation increased, suggesting that obesity induced ER stress in β-cells. Expression of the Bip/GRP78 protein was further increased in Wfs1^<-/-> A^y/a mice as compared to Wfs1^<-/-> or A^y/a mice. Electron micrography revealed markedly dilated ERs and decreased insulin granules in β-cells, suggesting that insulin resistance causes ER stress, and that pancreatic β-cells lacking Wfs1 are more susceptible to ER stress-induced apoptosis. Interestingly, pioglitazone treatment almost completely prevented diabetes, and protected β-cells form apoptosis. In islets, despite no difference in ER chaperone expression, CHOP expression was reduced. Although Wolfram syndrome is a distinct disease, there may be common processes involving slow, but progressive β-cell loss in patients with type 2 diabetes mellitus, in whom insulin demands rise continuously due to insulin resistance. Investigation of this model is anticipated to provide insights into the mechanism and prevention of β-cell loss. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
wfs1欠損マウスではインスリン需要増大時に膵β細胞が選択的に脱落する
当胰岛素需求增加时,wfs1缺陷小鼠的胰腺β细胞选择性脱落
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[秋山優, 他]
通讯作者:
他
糖尿病学 基礎と臨床(門脇孝他編集)(分担執筆)
糖尿病学基础与临床(由 Takashi Kadowaki 等人编辑)(撰稿人)
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[谷滓幸生, 他]
通讯作者:
他
DOI:
10.1016/j.diabres.2005.12.007
发表时间:
2006-08-01
期刊:
DIABETES RESEARCH AND CLINICAL PRACTICE
影响因子:
5.1
作者:
[Nakamura, Akinobu, Shimizu, Chikara, Koike, Takao]
通讯作者:
Koike, Takao
Increased Insulin Demand Causes Pancreatic β-Cell Apoptosis in the Wfs1 Knock-Out Mice.
胰岛素需求增加导致 Wfs1 敲除小鼠的胰腺 β 细胞凋亡。
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Akiyama M, Ueda K, Hatanaka M, Tsuru M, Miyazaki M, et al.]
通讯作者:
et al.
膵β細胞研究の進歩(寺内 康夫編集)(分担執筆)
胰腺β细胞的研究进展(寺内康雄主编)(撰稿人)
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[植田 浩平, 他]
通讯作者:
他
共 35 条
Peripheral Circadian Dysregulation and Metabolic Disorders
-
批准号:15H04849
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.23万
-
财政年份:2015
-
负责人:TANIZAWA Yukio
-
依托单位:
Investigation of the mechanism of beta-cell failure in diabetes using Wolfram Syndrome as a model
-
批准号:23390080
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2011
-
负责人:TANIZAWA Yukio
-
依托单位:
Investigation of the mechanism of pancreatic beta-cell death underlying progressive nature of type 2 diabetes mellitus, aiming at the development of treatment strategy for the disease condition.
-
批准号:20390093
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2008
-
负责人:TANIZAWA Yukio
-
依托单位:
Molecular Pathophysiology of Wolfram Syndrome and Endoplasmic Reticulum Stress-associated Pancreatic β-cell Failure.
-
批准号:16390096
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.41万
-
财政年份:2004
-
负责人:TANIZAWA Yukio
-
依托单位:
Investigation of the roles of WFS1 and glutamate dehydorogenase on the pancreatic β-cell function and regulation of insulin secretion
-
批准号:14370338
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:2002
-
负责人:TANIZAWA Yukio
-
依托单位:
In vitro induction of pancreatic β-cell development from mouse embryonic stem cells
-
批准号:12671113
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2000
-
负责人:TANIZAWA Yukio
-
依托单位:
Elucidation of molecular pathophysiology and development of the methods for molecular diagnosis of the disease associated with WFS1 gene mutations.
-
批准号:11557012
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.49万
-
财政年份:1999
-
负责人:TANIZAWA Yukio
-
依托单位:
Regulation of Pacreatic β-cell Function by Transcription Factors.
-
批准号:10671074
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:TANIZAWA Yukio
-
依托单位:
海外基金